Safety and Efficacy of Autologous SVF Cells in Treating Patients With Osteoarthritis

NCT02846675 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis

Interventions

BIOLOGICAL: autologous SVF
BIOLOGICAL: Placebo

Sponsor

Shanghai East Hospital